Study guide

3.3 Acute & Chronic Viral Hepatitis & Pancreatitis

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

3.3 Acute & Chronic Viral Hepatitis & Pancreatitis

Key Takeaways Explain This Topic AI

Hepatitis B serology interpretation relies on key markers: HBsAg indicates active infection, IgM anti-HBc indicates acute infection (positive in window period), and anti-HBs confers immunity.

Hepatitis E virus (HEV) causes self-limiting acute infection but carries a high mortality rate (~20–25%) due to fulminant hepatic failure in pregnant women during the third trimester.

Acute pancreatitis diagnosis requires at least 2 of 3 criteria: characteristic epigastric abdominal pain radiating to the back, serum lipase or amylase >3x upper limit of normal, and characteristic cross-sectional imaging.

Early management of acute pancreatitis centers on goal-directed crystalloid fluid resuscitation (Lactated Ringer's) within the first 24 hours; prophylactic antibiotics are not recommended routinely.

Chronic pancreatitis presents with the classic clinical triad of pancreatic calcifications on imaging, steatorrhea, and diabetes mellitus.

Last updated: July 2026

Acute & Chronic Viral Hepatitis & Pancreatitis

Gastroenterology questions in UPSC CMS frequently test viral hepatitis serology profiles, transmission routes, acute pancreatitis diagnostic guidelines (Revised Atlanta criteria), early resuscitation protocols, and chronic pancreatitis complications.

Viral Hepatitis: Etiology & Serology

Viral hepatitis is caused by primary hepatotropic viruses: Hepatitis A (HAV), B (HBV), C (HCV), D (HDV), and E (HEV).

Viral Transmission & Chronicity Risk

Enteric Transmission (Fecal-Oral):

HAV: Single-stranded RNA virus. Causes self-limiting acute hepatitis; never causes chronic disease .

HEV: Single-stranded RNA virus. Usually self-limiting, but causes fulminant hepatic failure with high mortality (20–25%) in pregnant females in their 3rd trimester.

Parenteral / Sexual / Perinatal Transmission:

HBV: Partially double-stranded DNA virus (Hepadnaviridae). Risk of chronicity depends on age at acquisition: perinatal transmission → 90 % \rightarrow 90\% → 90% chronicity risk; adult transmission → < 5 % \rightarrow <5\% →< 5% chronicity risk.

HCV: Single-stranded RNA virus (Flaviviridae). High rate of chronicity ( 75–85% ). Treated curatively with Direct-Acting Antivirals (DAAs, e.g., Sofosbuvir/Velpatasvir for 12 weeks with > 95 % >95\% > 95% Sustained Virologic Response [SVR]).

HDV: Defective delta RNA virus requiring HBsAg coat for virion assembly and infectivity. Co-infection (simultaneous HBV+HDV) vs. Superinfection (HDV added to chronic HBV; carries high risk of rapid cirrhosis).

Serological Markers of Hepatitis B Virus

  • Marker Definition Clinical Interpretation
  • HBsAg Hepatitis B surface antigen Indicates active infection (acute or chronic if present > 6 >6 > 6 months)

Anti-HBs Antibody to surface antigen Confers immunity and protection (positive after recovery or successful vaccination)

  • HBeAg Hepatitis B e-antigen Marker of active viral replication, high infectivity, and high serum HBV DNA
  • Anti-HBe Antibody to e-antigen Indicates lower viral replication (seroconversion)

IgM anti-HBc IgM antibody to core antigen Marker of ACUTE HBV infection ; sole positive marker during the Window Period

IgG anti-HBc IgG antibody to core antigen Indicates exposure to natural infection (past resolved or chronic; absent in vaccinated )

Diagnostic Profiles Matrix for HBV

Acute Infection: HBsAg (+), IgM anti-HBc (+), Anti-HBs (-), HBeAg (+).

Window Period: HBsAg (-), Anti-HBs (-), IgM anti-HBc (+) .

Chronic Infection (High Replication): HBsAg (+) > 6 >6 > 6 months, IgG anti-HBc (+), HBeAg (+), Anti-HBs (-).

Resolved Past Infection: HBsAg (-), Anti-HBs (+), IgG anti-HBc (+) .

Vaccination Immunity: HBsAg (-), Anti-HBs (+) , IgG anti-HBc (-).

Acute Pancreatitis

Acute pancreatitis is an acute inflammatory process of the pancreas resulting from premature intra-acinar enzyme activation.

Etiology

Gallstones (40%): Most common cause overall (biliary pancreatitis due to ampullary obstruction).

Alcohol (30%): Second most common cause.

Hypertriglyceridemia: Serum triglycerides > 1000 mg/dL >1000\text{ mg/dL} > 1000 mg/dL ( 11.3 mmol/L 11.3\text{ mmol/L} 11.3 mmol/L ).

Post-ERCP: Occurs in 3–10% of diagnostic/therapeutic procedures.

Hypercalcemia, Trauma, Drugs: (Azathioprine, Furosemide, Valproate, Sulfonamides).

Diagnostic Criteria (Revised Atlanta Criteria 2012)

Requires at least 2 of the following 3 criteria :

Abdominal pain: Severe, sharp epigastric pain radiating directly to the back, characteristically partially relieved by sitting upright and leaning forward ( Mohammedan posture ).

Biochemical markers: Serum Lipase or Amylase elevated > 3 >3 > 3 times the upper limit of normal (ULN). Serum lipase is more specific, rises earlier, and remains elevated longer (8–14 days) than amylase.

Imaging: Contrast-enhanced computed tomography (CECT), MRI, or transabdominal ultrasound demonstrating findings characteristic of acute pancreatitis.

CECT Timing: Early CECT within 24–48 hours of onset is inaccurate for assessing pancreatic necrosis. Optimal timing for CECT abdomen is 72 hours post-symptom onset .

Physical Examination Signs

Cullen Sign: Periumbilical blue-purple ecchymosis (indicates hemoperitoneum from necrotizing pancreatitis).

Grey Turner Sign: Flank ecchymosis (indicates retroperitoneal hemorrhage).

Fox Sign: Ecchymosis over the anteromedial thigh near the inguinal ligament.

Management Protocols

Fluid Resuscitation: Immediate goal-directed crystalloid administration ( Lactated Ringer's preferred over Normal Saline to decrease systemic inflammation and hyperchloremic acidosis) at 200 – 500 mL/hr 200–500\text{ mL/hr} 200–500 mL/hr or 5 – 10 mL/kg/hr 5–10\text{ mL/kg/hr} 5–10 mL/kg/hr . Monitor urine output ( > 0.5 mL/kg/hr >0.5\text{ mL/kg/hr} > 0.5 mL/kg/hr ) and hematocrit reduction.

Nutritional Support: Early oral feeding with low-fat solid diet as tolerated. If oral route failed, enteral tube feeding (nasogastric or nasojejunal) is superior to total parenteral nutrition (TPN) by preserving gut mucosal barrier integrity.

Antibiotics Rule: Prophylactic antibiotics are NOT recommended in acute pancreatitis regardless of severity or sterile necrosis. Antibiotics are indicated only for confirmed infected pancreatic necrosis (diagnosed via CT-guided fine-needle aspiration showing bacteria/fungi or gas bubbles on CECT).

Chronic Pancreatitis

Progressive, irreversible inflammatory and fibrotic disease of the pancreas leading to permanent destruction of exocrine and endocrine parenchyma.

Classic Clinical Triad

Pancreatic Calcifications: Visualized on abdominal radiograph or CECT (pathognomonic).

Steatorrhea: Exocrine insufficiency occurring when > 90 % >90\% > 90% of lipase-secreting capacity is destroyed (bulky, foul-smelling, oily stools).

Diabetes Mellitus: Endocrine insufficiency from islet cell loss (Pancreatogenic / Type 3c Diabetes).

Diagnostic Tests & Management

Fecal Elastase-1: Most sensitive non-invasive test for exocrine pancreatic insufficiency ( < 200 μ g/g <200\text{ }\mu\text{g/g} < 200 μ g/g indicates insufficiency; < 100 μ g/g <100\text{ }\mu\text{g/g} < 100 μ g/g severe).

Treatment: Pancreatic Enzyme Replacement Therapy ( PERT : enteric-coated lipase/protease/amylase microtablets taken during meals), alcohol/smoking cessation, low-fat frequent meals, and insulin for Type 3c diabetes.

Loading diagram... Diagnostic & Management Protocol for Acute Pancreatitis